April 15, 2024
TOPLINE: A low-fat vegan diet — high in fiber and carbohydrates and moderate in protein — reduces insulin requirement, increases insulin sensitivity, and improves glycemic control […]
April 15, 2024
(Reuters) – The cybersecurity firm BrandShield has taken down more than 250 websites selling fake versions of popular weight-loss and diabetes drugs in the GLP-1 class, […]
April 12, 2024
TOPLINE: Endoscopic sleeve gastroplasty (ESG) is more cost-effective, and achieves and sustains greater weight loss, than semaglutide over a 5-year period in patients with class II […]
April 12, 2024
TOPLINE: Adolescents with type 1 diabetes (T1D) experience a similar incidence of nighttime hypoglycemia after exercise as after sedentary days, reports a study exploring factors that […]
April 12, 2024
TOPLINE: No significant association was found between the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and thyroid cancer over nearly 4 years. METHODOLOGY: A […]
April 12, 2024
(Reuters) – The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk’s hugely popular Wegovy, are […]
April 11, 2024
TOPLINE: Breaking up long sitting periods with short, frequent bouts of light-intensity walks may reduce the increased levels of postprandial vascular inflammatory biomarkers seen in people […]
April 11, 2024
TOPLINE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be a better adjunct treatment to reduce anemia risk than glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for patients […]
April 10, 2024
TOPLINE: Surgery and radioactive iodine (RAI) are associated with a lower risk for long-term major adverse cardiovascular events (MACE) than long-term use of antithyroid drugs in […]